Sleep pill may quiet Brain's cannabis cravings
NCT ID NCT06584942
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study tests whether suvorexant (Belsomra), a sleep medication, can lower brain activity linked to cannabis cravings. Twenty adults who use cannabis daily will take the drug for 14 days and undergo brain scans before and after. The goal is to see if the medication reduces the brain's response to cannabis-related cues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANNABIS USE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Addiction Medicine, Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Genes may determine who gets hooked or psychotic from cannabis
- Could a sleep drug curb impulsivity in opioid recovery?
- Could a natural brain chemical help tame cannabis cravings and lift mood?
- Brain scans reveal hidden links between depression, cannabis, and HIV in young adults
- Brain zaps could curb cannabis cravings in youth
- New pill aims to take the edge off quitting weed